Protective effects of adenosine A2A receptor agonist in ventilator-induced lung injury in rats

Critical Care Medicine

Volumn 37, Issue 7, 2009, Pages 2235-2241

  Chen, Chin Ming ^a,b,c   Penuelas, Oscar ^c,e   Quinn, Kieran ^c,e   Cheng, Kuo Chen ^a,b,d   Li, Chien Feng ^a   Zhang, Haibo ^c,d,e   Slutsky, Arthur S ^c,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute Respiratory distress syndrome; Inflammation; Neutrophils

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; ADENOSINE; ADENOSINE A2A RECEPTOR; CYTOKINE; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BREATHING MECHANICS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HEMORRHAGIC SHOCK; INFLAMMATION; LUNG COMPLIANCE; LUNG EDEMA; LUNG INFILTRATE; LUNG INJURY; MALE; NEUTROPHIL; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RAT; RESUSCITATION; TIDAL VOLUME; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; BLOOD; BLOOD PRESSURE; DISEASE MODEL; DRUG POTENTIATION; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CYTOKINES; DISEASE MODELS, ANIMAL; MALE; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MECHANICS; SHOCK, HEMORRHAGIC; VENTILATOR-INDUCED LUNG INJURY;

EID: 67649764045     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a55273     Document Type: Article

References (43)

1. Toda Y, Takahashi T, Maeshima K, et al: A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats. Int J Mol Med 2007; 19:237-243
2. Rotstein OD: Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. J Trauma 2003; 54:203-206
3. Schulman AM, Claridge JA, Ghezel-Ayagh A, et al: Differential local and systemic tumor necrosis factor-alpha responses to a second hit of lipopolysaccharide after hemorrhagic shock. J Trauma 2003; 55:298-307
4. Crimi E, Zhang H, Han RN, et al: Ischemia and reperfusion increases susceptibility to ventilator-induced lung injury in rats. Am J Respir Crit Care Med 2006; 174:178-186
5. Bouadma L, Dreyfuss D, Ricard JD, et al: Mechanical ventilation and hemorrhagic shock-resuscitation interact to increase inflammatory cytokine release in rats. Crit Care Med 2007; 35:2601-2606
6. Antonioli L, Fornai M, Colucci R, et al: Pharmacological modulation of adenosine system: Novel options for treatment of inflammatory bowel diseases. Inflamm Bowel Dis 2008; 14:566-574
7. Headrick JP, Hack B, Ashton KJ: Acute adenosinergic cardioprotection in ischemicreperfused hearts. Am J Physiol Heart Circ Physiol 2003; 285:1797-1818
8. Linden J: Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001; 41:775-787
9. Fredholm BB: Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007; 14:1315-1323
10. Kaufmann I, Hoelzl A, Schliephake F, et al: Effects of adenosine on functions of polymorphonuclear leukocytes from patients with septic shock. Shock 2007; 27:25-31
11. Fredholm BB, Cunha RA, Svenningsson P: Pharmacology of adenosine A2A receptors and therapeutic applications. Curr Top Med Chem 2003; 3:413-426
12. Haskó G, Xu DZ, Lu Q, et al: Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock. Crit Care Med 2006; 34:1119-1125
13. Douillet CD, Robinson WP III, Milano PM, et al: Nucleotides induce IL-6 release from human airway epithelia via P2Y2 and p38 MAPK-dependent pathways. Am J Physiol Lung Cell Mol Physiol 2006; 291:L734-L746
14. Eckle T, Füllbier L, Wehrmann M, et al: Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 2007; 178:8127-8137
15. Haskó G, Cronstein BN: Adenosine: An endogenous regulator of innate immunity. Trends Immunol 2004; 25:33-39
16. Fortin A, Harbour D, Fernandes M, et al: Differential expression of adenosine receptors in human neutrophils: Up-regulation by specific Th1 cytokines and lipopolysaccharide. J Leukoc Biol 2006; 79:574-585
17. Rivo J, Zeira E, Galun E, et al: Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases. Shock 2007; 27:266-273
18. Reece TB, Laubach VE, Tribble CG, et al: Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury. Ann Thorac Surg 2005; 79:1189-1195
19. McPherson JA, Barringhaus KG, Bishop GG, et al: Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler Thromb Vasc Biol 2001; 21: 791-796
20. Reutershan J, Cagnina RE, Chang D, et al: Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol 2007; 179:1254-1263
21. Sullivan GW, Linden J, Buster BL, et al: Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: Synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis 1999; 180: 1550-1560
22. Ko SC, Zhang H, Haitsma JJ, et al: Effects of PEEP levels following repeated recruitment maneuvers on ventilator-induced lung injury. Acta Anaesthesiol Scand 2008; 52: 514-521
23. Drury AN, Szent-Györgyi A: The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 1929; 68:213-237
24. Tung CS, Chu KM, Tseng CJ, et al: Adenosine in hemorrhagic shock: Possible role in attenuating sympathetic activation. Life Sci 1987; 41:1375-1382
25. Haskó G, Sitkovsky MV, Szabo C: Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 2004; 25: 152-157
26. Spicuzza L, Di Maria G, Polosa R: Adenosine in the airways: Implications and applications. Eur J Pharmacol 2006; 533:77-88
27. Eckle T, Grenz A, Laucher S, et al: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 2008; 118: 3301-3315
28. Tremblay L, Valenza F, Ribeiro SP, et al: Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944-952
29. Ranieri VM, Suter PM, Tortorella C, et al: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 1999; 282:54-61
30. Tremblay LN, Miatto D, Hamid Q, et al: Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. Crit Care Med 2002; 30:1693-1700
31. Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997; 111:1306-1321
32. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308
33. Gajic O, Dara SI, Mendez JL, et al: Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 2004; 32: 1817-1824
34. Malek TR: The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol 2003; 74:961-965
35. Gasson JC, Weisbart RH, Kaufman SE, et al: Purified human granulocyte-macrophage colony-stimulating factor: Direct action on neutrophils. Science 1984; 226:1339-1342
36. Khatami S, Brummer E, Stevens DA: Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) in vivo on cytokine production and proliferation by spleen cells. Clin Exp Immunol 2001; 125:198-201
37. Van der Poll T, Jansen J, Levi M, et al: Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994; 180:1985-1988
38. Scumpia PO, Moldawer LL: Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med 2005; 33: 468-471
39. Abraham E: Neutrophils and acute lung injury. Crit Care Med 2003; 31:S195-S199
40. Lee WL, Downey GP: Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7:1-7
41. Day YJ, Marshall MA, Huang L, et al: Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: Inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 2004; 286:285-293
42. Okusa MD, Linden J, Macdonald T, et al: Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am J Physiol 1999; 277:404-412
43. Eltzschig HK, Ibla JC, Furuta GT, et al: Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A2B receptors. J Exp Med 2003; 198:783-796